RT Journal Article
SR Electronic
T1 Recurrent stroke prediction by applying a stroke polygenic risk score in the Japanese population
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.17.24309034
DO 10.1101/2024.06.17.24309034
A1 Kojima, Naoki
A1 Koido, Masaru
A1 He, Yunye
A1 Shimmori, Yuka
A1 Hachiya, Tsuyoshi
A1 ,
A1 Debette, Stéphanie
A1 Kamatani, Yoichiro
YR 2024
UL http://medrxiv.org/content/early/2024/06/17/2024.06.17.24309034.abstract
AB Background Recently, various polygenic risk score (PRS)-based methods were developed to improve stroke prediction. However, current PRSs (including cross-ancestry PRS) poorly predict recurrent stroke. Here, we aimed to determine whether the best PRS for Japanese individuals can also predict stroke recurrence in this population by extensively comparing the methods and maximizing the predictive performance for stroke onset.Methods We used data from the BioBank Japan (BBJ) 1st cohort (n=179,938) to derive and optimize the PRSs using a 10-fold cross-validation. We integrated the optimized PRSs for multiple traits, such as vascular risk factors and stroke subtypes to generate a single PRS using the meta-scoring approach (metaGRS). We used an independent BBJ 2nd cohort (n=41,929) as a test sample to evaluate the association of the metaGRS with stroke and recurrent stroke.Results We analyzed recurrent stroke cases (n=174) and non-recurrent stroke controls (n=1,153) among subjects within the BBJ 2nd cohort. After adjusting for known risk factors, metaGRS was associated with stroke recurrence (adjusted OR per SD 1.18 [95% CI: 1.00–1.39, p=0.044]), although no significant correlation was observed with the published PRSs. We administered three distinct tests to consider the potential index event bias; however, the outcomes derived from these examinations did not provide any significant indication of the influence of index event bias. The high metaGRS group without a history of hypertension had a higher risk of stroke recurrence than that of the low metaGRS group (adjusted OR 2.24 [95% CI: 1.07–4.66, p=0.032]). However, this association was weak in the hypertension group (adjusted OR 1.21 [95% CI: 0.69–2.13, p=0.50]).Conclusions The metaGRS developed in a Japanese cohort predicted stroke recurrence in an independent cohort of patients. In particular, it predicted an increased risk of recurrence among stroke patients without hypertension. These findings provide clues for additional genetic risk stratification and help in developing personalized strategies for stroke recurrence prevention.Competing Interest StatementY.K. holds stock of Staten Co., Ltd.Funding StatementThis research was supported by the Ministry of Education, Culture, Sports, Sciences and Technology (MEXT) of the Japanese government and the Japan Agency for Medical Research and Development (AMED) under grant nos. JP18km0605001/ JP23tm0624002 (the BioBank Japan project), JP223fa627011 (Y.K.), and JP23tm0524003 (Y.K.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of the Institute of Medical Science, the University of TokyoI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe weights of metaGRS derived in this study will be publicly available after acceptance. Genotype datasets were deposited in the National Bioscience Database Center Human Database (BBJ1, Research ID: hum0014; BBJ2, Research ID: hum0311).PRSpolygenic risk scoreP+Tpruning and thresholdingBBJBioBank JapanBBJ1BBJ 1st cohortBBJ2BBJ 2nd cohortToMMoTohoku Medical MegabankAISall ischemic strokeIPWinverse probability weightingLDlinkage disequilibriumGWASgenome-wide association studyPCprincipal componentIPWinverse probability weightAUCarea under the curveLASlarge artery strokeSVSsmall vessel strokeCEScardioembolic strokeTIStransient ischemic attackHWEHardy-Weinberg equilibriumWGSwhole genome sequencingMImyocardial infarctionSAPstable angina pectorisAPunstable angina pectorisAFatrial fibrillationDMdiabetes mellitusSMsmokingBMIbody mass indexHEheightSBPsystolic blood pressureDBPdiastolic blood pressureTCtotal cholesterolTGtriglycerideHDLhigh-density lipoproteinLDLlow-density lipoprotein